Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Klaris Diagnostics is raising $7,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Nick Arab played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Klaris Corp

At Klaris Diagnostics our mission is to enable targeted treatment for healthcare-associated infections to improve patient outcomes and slow the emergence of bacteria that are resistant to existing antibiotics. Klaris will leverage its powerful technology and the best talent in the field in order to fulfill this mission.

To learn more about Klaris Corp, visit http://klarisdx.com/

Contact:
Nick Arab, Chief Executive Officer
512-784-8706
narab@klarisdx.com
https://www.linkedin.com/in/nicolas-arab-35b2a83/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved